Advertising Feature: This podcast is from a partner and was not produced by GreenState.

Welcome to the Green Rush, a KCSA Strategic Communications Production, a weekly conversation at the intersection of cannabis, psychedelics, the capital markets and culture.

This week Nick Opich and Anne Donohoe are back to kick off 2024 with our last recording of 2023. Special guest Dr. Hans Eriksson, Chief Medical Officer for HMNC Brain Health, joins us this week to ring in the New Year, discussing his role at HMNC, the company’s research and development efforts to identify and bring to market treatments for mental health disorders, and the latest news and progress on the psychedelics movement.

In this episode, Hans also discusses the death of the beloved actor Matthew Perry, his ketamine use and how the news was presented by the media, and the risks associated with the treatment.

If you are interested in learning more about Hans or to check out the latest updates from HMNC Brain Health, visit the links in our show notes. Also, be sure to follow HMNC and Hans on LinkedIn.

So, sit back and enjoy our conversation with Dr. Hans Eriksson of HMNC Brain Health.

Links, mentions, and socials:

• HMNC Brain Health: hmnc-brainhealth.com
• HMNC Brain Health LinkedIn: de.linkedin.com/company/hmnc-brain-health
• Dr. Hans Eriksson LinkedIn: linkedin.com/in/hansaeriksson

Show Credits:

This episode was hosted by Nick Opich and Anne Donohoe of KCSA Strategic Communications. 

Special thanks to our Program Director Shea Gunther.

You can learn more about how KCSA can help your cannabis and psychedelic companies by visiting www.kcsa.com or emailing greenrush@kcsa.com. You can also connect with us via our social channels:

X: @The_GreenRush

Instagram: @thegreenrush_podcast

LinkedIn: linkedin.com/company/thegreenrushpodcast

Facebook: facebook.com/TheGreenRushPodcast 

YouTube: youtube.com/channel/UCuEQkvdjpUnPyhF59wxseqw?disable_polymer=true